Insights into Molecular cancer therapy: NOS-2 suppresses the expression of tumor suppressor GRHL3 via up regulation of its target gene, 18/February/2014, 10.49 am

Tumorigenesis: The antifungal agent Fenhexamid suppresses the expression of tumor suppressor KRIT1/CCM1 via up regulation of its target gene, 18/February/2014, 10.43 am
February 18, 2014
Proliferation: 1α,25-dihydroxyvitamin D(3) increases the expression of E2F5 via down regulation of its target gene, 19/February/2014, 8.40 am
February 19, 2014
Show all

Noble Laureate in Medicine (1998) Prof. Dr Feirid  (The University of Texas, Houston, Texas, USA) has suggested in a number of papers that inhibition of NOS2 (Nitric oxide synthase) may have a therapeutic value in a number of cancers.  

In connection with this finding, Dr L Boominathan, Director-cum-chief scientist of GBMD, reports that: Molecular insights into Cancer therapy: NOS-2 suppresses the expression of tumor suppressor GRHL3  via up regulation of its target gene. This study provides mechanistic insights into how inhibition of NOS-2 may improve caner therapy.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Insights into Molecular cancer therapy: NOS-2 suppresses the expression of tumor suppressor GRHL3 via up regulation of its target gene, 18/February/2014, 10.49 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.